CLASS II Drug recall · Reported 16 May 2018 · FDA Enforcement Report

Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL recalled

Vitalab Pharmacy is recalling Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phentolamine, distributed nationwide in the US. The recall was initiated on 24 Apr 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #:T101 03062018@69, 02052018@56, T104 03122018@62, 02072018@95, T105 03122018@63, 02072018@96, T106 03122018@64, 02072018@97, Exp 06/04/2018-06/10/2018
Quantity recalled60 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0733-2018
FDA event ID
80000
Recalling firm
Vitalab Pharmacy, Phoenix, AZ
Classification
Class II
Status
Terminated
Recall initiated
24 Apr 2018
FDA classified
9 May 2018
Reported
16 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

24 Apr 2018Recall initiated by company
9 May 2018Classified by FDA+15 days
16 May 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 10mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 25mcg/mL, sterile injectables, Vitalab Pharmacy, Inc

Where it was distributed

The recalled product was distributed to patients throughout the United States.

Nationwide

Questions about this recall

Why was it recalled?

Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Which lots are affected?

Lot #:T101 03062018@69, 02052018@56, T104 03122018@62, 02072018@95, T105 03122018@63, 02072018@96, T106 03122018@64, 02072018@97, Exp 06/04/2018-06/10/2018

Where was it sold?

The recalled product was distributed to patients throughout the United States.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 80000

This product is part of a recall event; the main page for the event is Methylcobalamin for injection, 1mg/mL and 10 mg/mL recalled.

More recalls from Vitalab Pharmacy

All 6

Other Papaverine recalls

All 64